Trials / Completed
CompletedNCT04196075
The Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective cohort study on the effect of Andrographis Paniculata (AP) on palliative management of patients with advanced or metastatic esophageal cancer. A total of 30 patients with locally advanced or metastatic squamous esophageal cancer will be recruited for the trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Andrographis Paniculata | AP as palliative treatment |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2021-02-28
- Completion
- 2021-06-30
- First posted
- 2019-12-12
- Last updated
- 2021-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04196075. Inclusion in this directory is not an endorsement.